Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II

[1]  A. Mügge,et al.  Multipoint left ventricular pacing with large anatomical separation improves reverse remodeling and response to cardiac resynchronization therapy in responders and non-responders to conventional biventricular pacing , 2019, Clinical Research in Cardiology.

[2]  G. Hindricks,et al.  Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial , 2019, Clinical Research in Cardiology.

[3]  S. Hohnloser,et al.  ICD lead type and RV lead position in CRT-D recipients , 2018, Clinical Research in Cardiology.

[4]  Wolfgang Hoffmann,et al.  Telemedical monitoring of patients with chronic heart failure has a positive effect on total health costs , 2018, BMC Health Services Research.

[5]  G. Hindricks,et al.  CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how? , 2018, European journal of heart failure.

[6]  Gerhard Hindricks,et al.  A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[8]  G. Hindricks,et al.  European cardiac resynchronization therapy survey II: rationale and design. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  G. Hindricks,et al.  Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.

[10]  S. Solomon,et al.  Survival with cardiac-resynchronization therapy in mild heart failure. , 2014, The New England journal of medicine.

[11]  G. Andrikopoulos,et al.  Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. , 2014, The New England journal of medicine.

[12]  J. Nielsen,et al.  ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .

[13]  William T. Abraham,et al.  Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex , 2013 .

[14]  Lluís Mont,et al.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[16]  William T. Abraham,et al.  An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure , 2013, European heart journal.

[17]  Anne B Curtis,et al.  Biventricular pacing for atrioventricular block and systolic dysfunction. , 2013, The New England journal of medicine.

[18]  J. Daubert,et al.  Long‐term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization‐Heart Failure (CARE‐HF) trial , 2012, European journal of heart failure.

[19]  P. Sanders,et al.  Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. , 2012, Journal of the American College of Cardiology.

[20]  M. Brignole,et al.  Predictors of clinical efficacy of ‘Ablate and Pace’ therapy in patients with permanent atrial fibrillation , 2011, Heart.

[21]  P. Heidenreich,et al.  Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. , 2011, Heart rhythm.

[22]  W. Ghali,et al.  Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. , 2011, Heart rhythm.

[23]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[24]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[25]  K. Dickstein,et al.  The European cardiac resynchronization therapy survey. , 2009, European heart journal.

[26]  Stefano Ghio,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[27]  M. Metra,et al.  Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation , 2008, European heart journal.

[28]  J. Ottervanger,et al.  Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. , 2007, The American journal of cardiology.

[29]  Catherine Klersy,et al.  Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.

[30]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[31]  J. Schroeder,et al.  Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure , 2004, Circulation.

[32]  R. Canby,et al.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.

[33]  J. Daubert,et al.  Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. , 2002, European heart journal.

[34]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[35]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[36]  J. Daubert,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.

[37]  J. Daubert,et al.  Four Chamber Pacing in Dilated Cardiomyopathy , 1994, Pacing and clinical electrophysiology : PACE.